E.E. Geduld’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

E.E. Geduld’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$933K	Buy	75,000 +20,000	+36%	+$241K	0.52%	19
2016 Q3	$753K	Buy	55,000 +45,000	+450%	+$452K	0.75%	21
2016 Q2	$74K	Buy	+10,000	New	+$75K	0.1%	116
2015 Q3	–	Sell	-20,000	Closed	-$165K	–	302
2015 Q2	$165K	Buy	20,000 +10,000	+100%	+$88.4K	0.1%	191
2015 Q1	$82K	Buy	+10,000	New	+$73.9K	0.05%	204
2014 Q3	–	Sell	-25,000	Closed	-$159K	–	301
2014 Q2	$159K	Buy	+25,000	New	+$172K	0.1%	198

Other funds holding ARIA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

E.E. Geduld's ARIA Position: Q4 2016 in Review

E.E. Geduld increased its Ariad Pharmaceuticals Inc (ARIA) stake by 4.5% in Q4 2016, buying an estimated $60.2K and bringing the position to 115,900 shares worth $1.44M. The position accounts for 0.81% of the portfolio, ranked #7.

E.E. Geduld first reported a position in ARIA in Q4 2013 and has held it in 13 quarters since. The position peaked at $5.7M in Q4 2013. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

E.E. Geduld held 115,900 shares of Ariad Pharmaceuticals Inc worth $1.44M as of Q4 2016.
E.E. Geduld bought 5,000 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $60.2K.
Ariad Pharmaceuticals Inc made up 0.81% of E.E. Geduld's portfolio in Q4 2016, its #7 holding.
E.E. Geduld first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and has held it in 13 quarters since.
E.E. Geduld's Ariad Pharmaceuticals Inc position peaked at $5.7M in Q4 2013.
200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.